Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: Validation in a Brazilian cohort of adult and pediatric patients

European Journal of Endocrinology

Volumn 166, Issue 1, 2012, Pages 61-67

  Fragoso, Maria Candida B V ^a   Almeida, Madson Queiroz ^a   Mazzuco, Tania L ^b   Mariani, Beatriz M P ^a   Brito, Luciana P ^a   Gonçalves, Talita Cardoso ^a   Alencar, Guilherme A ^a   De Lima, Lorena O ^a   Faria, Andre M ^a   Bourdeau, Isabelle ^b   Lucon, Antonio M ^a   Freire, Daniel S ^a   Latronico, Ana Claudia ^a   Mendonca, Berenice B ^a   Lacroix, Andre ^b   Lerario, Antonio M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADRENAL CORTEX TUMOR; ARTICLE; BRAZILIAN; BUB1B GENE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DLGAP5 GENE; ETHNIC GROUP; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PINK1 GENE; POLYMERASE CHAIN REACTION; PREDICTOR VARIABLE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; SCHOOL CHILD; VALIDATION PROCESS;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; BRAZIL; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASM PROTEINS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; TUMOR MARKERS, BIOLOGICAL;

EID: 84055199656     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0806     Document Type: Article

References (20)

1. Barzon L, Sonino N, Fallo F, Palu G & Boscaro M. Prevalence and natural history of adrenal incidentalomas. European Journal of Endocrinology 2003 149 273-285. (doi:10.1530/eje.0.1490273)
2. Allolio B & Fassnacht M. Clinical review: adrenocortical carcinoma: clinical update. Journal of Clinical Endocrinology and Metabolism 2006 91 2027-2037. (doi:10.1210/jc.2005-2639)
3. Weiss LM, Medeiros LJ & Vickery AL Jr. Pathologic features of prognostic significance in adrenocortical carcinoma. American Journal of Surgical Pathology 1989 13 202-206. (doi:10.1097/00000478-198903000-00004)
4. Sandrini R, Ribeiro RC & DeLacerda L. Childhood adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 1997 82 2027-2031. (doi:10.1210/jc.82.7.2027)
5. Almeida MQ & Latronico AC. The molecular pathogenesis of childhood adrenocortical tumors. Hormone and Metabolic Research 2007 39 461-466. (doi:10.1055/s-2007-981476)
6. Ribeiro RC, Sandrini F, Figueiredo B, Zambetti GP, Michalkiewicz E, Lafferty AR, DeLacerda L, Rabin M, Cadwell C, Sampaio G, Cat I, Stratakis CA & Sandrini R. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. PNAS 2001 98 9330-9335. (doi:10.1073/pnas.161479898)
7. Latronico AC, Pinto EM, Domenice S, Fragoso MC, Martin RM, Zerbini MC, Lucon AM & Mendonca BB. An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 2001 86 4970-4973. (doi:10.1210/jc.86.10.4970)
8. Wieneke JA, Thompson LD & Heffess CS. Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients. American Journal of Surgical Pathology 2003 27 867-881. (doi:10.1097/00000478-200307000-00001)
9. de Fraipont F, El Atifi M, Cherradi N, Le Moigne G, Defaye G, Houlgatte R, Bertherat J, Bertagna X, Plouin PF, Baudin E, Berger F, Gicquel C, Chabre O & Feige JJ. Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy. Journal of Clinical Endocrinology and Metabolism 2005 90 1819-1829. (doi:10.1210/jc.2004-1075)
10. Giordano TJ, Thomas DG, Kuick R, Lizyness M, Misek DE, Smith AL, Sanders D, Aljundi RT, Gauger PG, Thompson NW, Taylor JM & Hanash SM. Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. American Journal of Pathology 2003 162 521-531. (doi:10.1016/S0002- 9440(10)63846-1)
11. West AN, Neale GA, Pounds S, Figueredo BC, Rodriguez Galindo C, Pianovski MA, Oliveira Filho AG, Malkin D, Lalli E, Ribeiro R & Zambetti GP. Gene expression profiling of childhood adrenocortical tumors. Cancer Research 2007 67 600-608. (doi:10.1158/0008-5472.CAN-06-3767)
12. Almeida MQ, Fragoso MC, Lotfi CF, Santos MG, Nishi MY, Costa MH, Lerario AM, Maciel CC, Mattos GE, Jorge AA, Mendonca BB & Latronico AC. Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 2008 93 3524-3531. (doi:10.1210/jc.2008-0065)
13. Doghman M, El Wakil A, Cardinaud B, Thomas E, Wang J, Zhao W, Peralta-Del Valle MH, Figueiredo BC, Zambetti GP & Lalli E. Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors. Cancer Research 2010 70 4666-4675. (doi:10.1158/0008- 5472.CAN-09-3970)
14. de Reynies A, Assie G, Rickman DS, Tissier F, Groussin L, Rene-Corail F, Dousset B, Bertagna X, Clauser E & Bertherat J. Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. Journal of Clinical Oncology 2009 27 1108-1115. (doi:10.1200/JCO.2008.18.5678)
15. Lima Lde O, Lerario AM, Alencar GA, Brito LP, Almeida MQ, Domenice S, Latronico AC, Mendonca BB & Fragoso MC. Clinical and molecular aspects of a pediatric metachronous adrenocortical tumor. Arquivos Brasileiros de Endocrinologia e Metabologia 2011 55 72-77. (doi:10.1590/S0004- 27302011000100010)
16. Giordano TJ, Kuick R, Else T, Gauger PG, Vinco M, Bauersfeld J, Sanders D, Thomas DG, Doherty G & Hammer G. Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clinical Cancer Research 2009 15 668-676. (doi:10.1158/1078-0432.CCR-08-1067)
17. Gudmundsson KO, Thorsteinsson L, Sigurjonsson OE, Keller JR, Olafsson K, Egeland T, Gudmundsson S & Rafnar T. Gene expression analysis of hematopoietic progenitor cells identifies Dlg7 as a potential stem cell gene. Stem Cells 2007 25 1498-1506. (doi:10.1634/stemcells.2005-0479)
18. Assie G, Guillaud-Bataille M, Ragazzon B, Bertagna X, Bertherat J & Clauser E. The pathophysiology, diagnosis and prognosis of adrenocortical tumors revisited by transcriptome analyses. Trends in Endocrinology and Metabolism 2010 21 325-334. (doi:10.1016/j.tem.2009.12.009)
19. Wang Q, Liu T, Fang Y, Xie S, Huang X, Mahmood R, Ramaswamy G, Sakamoto KM, Darzynkiewicz Z, Xu M & Dai W. BUBR1 deficiency results in abnormal megakaryopoiesis. Blood 2004 103 1278-1285. (doi:10.1182/blood-2003-06-2158)
20. Unoki M & Nakamura Y. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene 2001 20 4457-4465. (doi:10.1038/sj.onc.1204608)